The Global In-Vitro Toxicity Testing Market
The Global In-Vitro Toxicity Testing Market was valued at USD 10.2 billion in 2021 and is anticipated to reach at USD 18.6 billion by 2027 at a CAGR 10.8% from 2022-2027.
In Vitro is the process which used to examine harmful chemicals over the isolated part of the organism. The in-vitro toxicity testing is used to identify hazardous chemical substance and helps to determine toxicity at early-stage evolution of the new products such as drugs, cosmetics, and food additives. The in-vitro toxicity testing is chiefly used for safety assessment in drug development and also for arranging the chemicals according to their potency. The absorption, distribution, metabolism, and elimination (ADME), dose response, and threshold response of the drug can also be detected by in-vitro toxicity testing.
Market Drivers
Opposition to animal testing is anticipated to drive the growth of Global In-Vitro Toxicity Testing during the upcoming years. The rising requirement for in vitro-toxicity testing in various industry such as pharmaceuticals, chemicals and food industry that boost the growth of in-vitro toxicity testing market. Also, increasing in awareness of testing of various cosmetics, foods, and other products, that fuels the growth of the In-Vitro Toxicity Testing Market. The Global In-Vitro Toxicity Testing Market is anticipated to observe noteworthy growth during the forecast period owing to the rise in number of R&D procedures, that need in vitro-testing and growing awareness about the environmental concerns. Additionally, development in genetics and genetic screening approaches and arrival of new approaches of 3D cell culture boost the Global In-Vitro Toxicity Testing Market.
Market Restraints
Questionable predictive power of in-vitro toxicity testing is anticipated to restraint the growth of market. Also, the effect of nanomaterial properties on the result of in vitro toxicity testing through assay interference is anticipated to impede the growth of market.
Market Segmentation
The Global In-Vitro Toxicity Testing Market is segmented into Type, Technology, End User. By Type such as Absorption, Toxic Substances, Dose. By Technology such as Cell Culture Technologies, High Throughput Technologies, Toxicogenomics. By End User such as Cosmetics and Households Products, Pharmaceuticals Industry, Food Industry, Chemicals Industry.
Regional Analysis
The Global In-Vitro Toxicity Testing Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America influences the In-Vitro Toxicity Testing Market and accounted for the largest revenue share of over 4.7% due to raised focus of government bodies for drug discovery, increase in healthcare expenditure, and presence of satisfactory infrastructure for growth and development of drug discovery technologies. Asia Pacific, the market for In-Vitro Toxicity Testing is estimated to register comparatively rapid earn over the next seven 7 years due to development in healthcare infrastructure and increase in government incentives for research in government and private organization.
Various Key Players are listed in this report such as Merck KGaA, Charles River, Bio-Rad Laboratories, Inc., Abbott, Thermo Fisher Scientific Inc., Catalent, Inc., GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings.
By Technology
By Type
By End User
By Region
Global In-Vitro Toxicity Testing Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global In-Vitro Toxicity Testing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global In-Vitro Toxicity Testing Market, By Technology
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Technology
5.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Technology
5.3.1 Cell Culture Technologies
5.3.2 High Throughput Technologies
5.3.3 Toxicogenomics.
6 Global In-Vitro Toxicity Testing Market, By Type
6.1 Y-o-Y Growth Comparison, By Type
6.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Type
6.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Type
6.3.1 Absorption
6.3.2 Toxic Substances
6.3.3 Dose
7 Global In-Vitro Toxicity Testing Market, By End-user
7.1 Y-o-Y Growth Comparison, By End-user
7.2 Global In-Vitro Toxicity Testing Market Share Analysis, By End-user
7.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By End-user
7.3.1 Cosmetics and Households Products
7.3.2 Pharmaceuticals Industry
7.3.3 Food Industry
7.3.4 Chemicals Industry.
8 Global In-Vitro Toxicity Testing Market, By Region
8.1 Global In-Vitro Toxicity Testing Market Share Analysis, By Region
8.2 Global In-Vitro Toxicity Testing Market Share Analysis, By Region
8.3 Global In-Vitro Toxicity Testing Market Size and Forecast, By Region
9 North America In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America In-Vitro Toxicity Testing Market Share Analysis, By Type
9.3 North America In-Vitro Toxicity Testing Market Size and Forecast, By Technology
9.4 North America In-Vitro Toxicity Testing Market Size and Forecast, By End-use
9.6 North America In-Vitro Toxicity Testing Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe In-Vitro Toxicity Testing Market Share Analysis, By Type
10.3 Europe In-Vitro Toxicity Testing Market Size and Forecast, By Technology
10.4 Europe In-Vitro Toxicity Testing Market Size and Forecast, By End-user
10.5 Europe In-Vitro Toxicity Testing Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4. Rest of Europe
11 Asia Pacific In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific In-Vitro Toxicity Testing Market Share Analysis, By Type
11.3 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By Technology
11.4 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By End-user
11.5 Asia Pacific In-Vitro Toxicity Testing Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America In-Vitro Toxicity Testing Market Share Analysis, By Type
12.3 Latin America In-Vitro Toxicity Testing Market Size and Forecast, By Technology
12.4 Latin America In-Vitro Toxicity Testing Market Size and Forecast, By End-user
12.5 Latin America In-Vitro Toxicity Testing Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East In-Vitro Toxicity Testing Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East In-Vitro Toxicity Testing Market Share Analysis, By Type
13.3 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By Technology
13.4 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By End-user
13.5 Middle East In-Vitro Toxicity Testing Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Merck KGaA
15.1.1 Overview
15.1.2 Products
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Charles River
15.2.1 Overview
15.2.2 Products
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Bio-Rad Laboratories, Inc.
15.3.1 Overview
15.3.2 Products
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Abbott
15.4.1 Overview
15.4.2 Products
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Thermo Fisher Scientific Inc
15.5.1 Overview
15.5.2 Products
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Catalent, Inc.
15.6.1 Overview
15.6.2 Products
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 GE Healthcare
15.7.1 Overview
15.7.2 Products
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Quest Diagnostics Incorporated
15.8.1 Overview
15.8.2 Products
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Eurofins Scientific
15.9.1 Overview
15.9.2 Products
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Laboratory Corporation of America Holdings
15.10.1 Overview
15.10.2 Products
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
